Viemed Healthcare Statistics
Share Statistics
Viemed Healthcare has 38.94M shares outstanding. The number of shares has increased by 0.88% in one year.
Shares Outstanding | 38.94M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0.01% |
Owned by Institutions (%) | n/a |
Shares Floating | 34.02M |
Failed to Deliver (FTD) Shares | 433 |
FTD / Avg. Volume | 0.26% |
Short Selling Information
The latest short interest is 361.18K, so 0.93% of the outstanding shares have been sold short.
Short Interest | 361.18K |
Short % of Shares Out | 0.93% |
Short % of Float | 1.06% |
Short Ratio (days to cover) | 2.27 |
Valuation Ratios
The PE ratio is 29.39 and the forward PE ratio is 23.98. Viemed Healthcare 's PEG ratio is 0.47.
PE Ratio | 29.39 |
Forward PE | 23.98 |
PS Ratio | 1.65 |
Forward PS | 1.4 |
PB Ratio | 2.64 |
P/FCF Ratio | 15.75 |
PEG Ratio | 0.47 |
Enterprise Valuation
Viemed Healthcare Inc. has an Enterprise Value (EV) of 298.58M.
EV / Earnings | 29.15 |
EV / Sales | 1.63 |
EV / EBITDA | 8.13 |
EV / EBIT | 20.84 |
EV / FCF | 15.62 |
Financial Position
The company has a current ratio of 1.19, with a Debt / Equity ratio of 0.06.
Current Ratio | 1.19 |
Quick Ratio | 1.05 |
Debt / Equity | 0.06 |
Total Debt / Capitalization | 5.85 |
Cash Flow / Debt | 6.39 |
Interest Coverage | 33.8 |
Financial Efficiency
Return on equity (ROE) is 0.09% and return on capital (ROIC) is 8.21%.
Return on Equity (ROE) | 0.09% |
Return on Assets (ROA) | 0.07% |
Return on Capital (ROIC) | 8.21% |
Revenue Per Employee | 160.25K |
Profits Per Employee | 8.97K |
Employee Count | 1.14K |
Asset Turnover | 1.18 |
Inventory Turnover | 15.17 |
Taxes
Income Tax | 4.15M |
Effective Tax Rate | 0.29 |
Stock Price Statistics
The stock price has increased by 16.73% in the last 52 weeks. The beta is 1.44, so Viemed Healthcare 's price volatility has been higher than the market average.
Beta | 1.44 |
52-Week Price Change | 16.73% |
50-Day Moving Average | 8.83 |
200-Day Moving Average | 7.92 |
Relative Strength Index (RSI) | 48.38 |
Average Volume (20 Days) | 167.42K |
Income Statement
In the last 12 months, Viemed Healthcare had revenue of $183.01M and earned $10.24M in profits. Earnings per share was $0.27.
Revenue | 183.01M |
Gross Profit | 112.78M |
Operating Income | 14.33M |
Net Income | 10.24M |
EBITDA | 36.71M |
EBIT | 14.33M |
Earnings Per Share (EPS) | 0.27 |
Balance Sheet
The company has $12.84M in cash and $10.32M in debt, giving a net cash position of $2.52M.
Cash & Cash Equivalents | 12.84M |
Total Debt | 10.32M |
Net Cash | 2.52M |
Retained Earnings | 79.50M |
Total Assets | 169.53M |
Working Capital | 11.25M |
Cash Flow
In the last 12 months, operating cash flow was $45.21M and capital expenditures -$26.09M, giving a free cash flow of $19.12M.
Operating Cash Flow | 45.21M |
Capital Expenditures | -26.09M |
Free Cash Flow | 19.12M |
FCF Per Share | 0.5 |
Margins
Gross margin is 61.63%, with operating and profit margins of 7.83% and 5.6%.
Gross Margin | 61.63% |
Operating Margin | 7.83% |
Pretax Margin | 7.86% |
Profit Margin | 5.6% |
EBITDA Margin | 20.06% |
EBIT Margin | 7.83% |
FCF Margin | 10.45% |
Dividends & Yields
VMD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 3.1% |
FCF Yield | 5.63% |
Analyst Forecast
Currently there are no analyst rating for VMD.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | 7.23 |
Piotroski F-Score | 7 |